114 related articles for article (PubMed ID: 37823356)
21. Pharmacokinetics of ivermectin after oral and intravenous administration in Biłgorajska geese (
Sartini I; Łebkowska-Wieruszewska B; Krupa M; Lisowski A; Poapolathep A; Giorgi M
N Z Vet J; 2022 Nov; 70(6):313-318. PubMed ID: 35852416
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of fluconazole in loggerhead sea turtles (Caretta caretta) after single intravenous and subcutaneous injections, and multiple subcutaneous injections.
Mallo KM; Harms CA; Lewbart GA; Papich MG
J Zoo Wildl Med; 2002 Mar; 33(1):29-35. PubMed ID: 12216790
[TBL] [Abstract][Full Text] [Related]
23. Ivermectin and clorsulon (ivomec super) in treatment of goats naturally infested with scab mites and biting lice.
Morsy TA; Habib KS; Haridy FM
J Egypt Soc Parasitol; 2001 Aug; 31(2):373-9. PubMed ID: 11478437
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of ceftiofur sodium in cats following a single intravenous and subcutaneous injection.
Zhang M; Yang F; Yu HJ; Kang TJ; Ding YH; Yu ML; Wang QK; Zhu YX; Yang F
J Vet Pharmacol Ther; 2019 Nov; 42(6):602-608. PubMed ID: 31529627
[TBL] [Abstract][Full Text] [Related]
25. Plasma disposition and faecal excretion of eprinomectin following topical and subcutaneous administration in non-lactating dairy cattle.
Aksit D; Korkut O; Aksoz E; Gokbulut C
N Z Vet J; 2016 Jul; 64(4):207-11. PubMed ID: 26820168
[TBL] [Abstract][Full Text] [Related]
26. Role of the Abcg2 Transporter in Secretion into Milk of the Anthelmintic Clorsulon: Interaction with Ivermectin.
Blanco-Paniagua E; Álvarez-Fernández L; Rodríguez-Alonso A; Millán-Garcia A; Álvarez AI; Merino G
Antimicrob Agents Chemother; 2023 May; 67(5):e0009523. PubMed ID: 37078871
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of ivermectin in zebu Gobra (Bos indicus).
Ndong TB; Kane Y; Ba MA; Sane I; Sutra JF; Alvinerie M
Vet Parasitol; 2005 Mar; 128(1-2):169-73. PubMed ID: 15725548
[TBL] [Abstract][Full Text] [Related]
28. Assessment of dose proportionality, absolute bioavailability, and immunogenicity response of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following subcutaneous and intravenous administration to rats.
Srinivas NR; Shyu WC; Weiner RS; Warner G; Comereski C; Tay LK; Greene DS; Barbhaiya RH
Pharm Res; 1997 Jul; 14(7):911-6. PubMed ID: 9244149
[TBL] [Abstract][Full Text] [Related]
29. Comparative pharmacokinetics of florfenicol in heifers after intramuscular and subcutaneous administration.
Selimov R; Goncharova E; Koriakovtsev P; Gabidullina D; Karsakova J; Kozlov S; Komarov A; Engasheva E; Engashev S
J Vet Pharmacol Ther; 2023 May; 46(3):177-184. PubMed ID: 36633958
[TBL] [Abstract][Full Text] [Related]
30. Disposition kinetics of difloxacin after intravenous, intramuscular and subcutaneous administration in calves.
ismail M
Vet Res Commun; 2007 May; 31(4):467-76. PubMed ID: 17216308
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of eprinomectin in plasma and milk following subcutaneous administration to lactating dairy cattle.
Baoliang P; Yuwan W; Zhende P; Lifschitz AL; Ming W
Vet Res Commun; 2006 Apr; 30(3):263-70. PubMed ID: 16437302
[TBL] [Abstract][Full Text] [Related]
32. Breed differences in the pharmacokinetics of ivermectin administered subcutaneously to Holstein and Belgian Blue calves.
Vercruysse J; Deprez P; Everaert D; Bassissi F; Alvinerie M
Vet Parasitol; 2008 Mar; 152(1-2):136-40. PubMed ID: 18207642
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of selamectin following intravenous, oral and topical administration in cats and dogs.
Sarasola P; Jernigan AD; Walker DK; Castledine J; Smith DG; Rowan TG
J Vet Pharmacol Ther; 2002 Aug; 25(4):265-72. PubMed ID: 12213114
[TBL] [Abstract][Full Text] [Related]
34. The relative plasma availabilities of ivermectin in reindeer (Rangifer tarandus tarandus) following subcutaneous and two different oral formulation applications.
Oksanen A; Åsbakk K; Raekallio M; Nieminen M
Acta Vet Scand; 2014 Nov; 56(1):76. PubMed ID: 25421461
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in horses.
Abu-Basha EA; Bani Ismail Z; Ababneh MM; Hamzeh E; Gehring R
J Vet Pharmacol Ther; 2021 Jul; 44(4):544-551. PubMed ID: 33609061
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of subcutaneously administered doramectin in alpacas.
Lye G; Jacob A; Pomroy W; Stafford K; Singh P
J Vet Pharmacol Ther; 2020 Mar; 43(2):123-128. PubMed ID: 31660626
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of a new long acting endectocide formulation containing 2.25% ivermectin and 1.25% abamectin in cattle.
Borges FA; Cho HS; Santos E; Oliveira GP; Costa AJ
J Vet Pharmacol Ther; 2007 Feb; 30(1):62-7. PubMed ID: 17217403
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and bioequivalence of parenterally administered doramectin in cattle.
Nowakowski MA; Lynch MJ; Smith DG; Logan NB; Mouzin DE; Lukaszewicz J; Ryan NI; Hunter RP; Jones RM
J Vet Pharmacol Ther; 1995 Aug; 18(4):290-8. PubMed ID: 8583542
[TBL] [Abstract][Full Text] [Related]
39. Comparison of pharmacokinetic profiles of doramectin and ivermectin pour-on formulations in cattle.
Gayrard V; Alvinerie M; Toutain PL
Vet Parasitol; 1999 Feb; 81(1):47-55. PubMed ID: 9950328
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic efficacy of clorsulon against Fasciola hepatica in calves and sheep.
Fetterer RH; Rew RS; Gasbarre LC; Ostlind DA
Vet Parasitol; 1985 Jun; 18(1):21-7. PubMed ID: 4049724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
